A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Bordeaux Hopital Saint Andre
Bordeaux, France
Withdrawn - Clcc Institut Bergonie
Bordeaux, France
Antoine ItalianoRecruiting - Centre Oscar Lambret
Lille, France
Cyril AbdeddaimRecruiting - Centre Leon Berard
Lyon, France
Medhi BrahmiRecruiting - Chu Nantes Hopital Hotel Dieu
Nantes, France
Thomas GastinneRecruiting - Chu Nantes Hopital Hotel Dieu
Nantes, France
Caroline VialaRecruiting - Chu Nantes Hopital Nord Laennec
Saint-Herblain, France
Thomas GastinneRecruiting - Institut Cancerologie de Strasbourg
Strasbourg, France
Lauriane EberstRecruiting - Clcc Institut Gustave Roussy
Villejuif, France
Vincent RibragRecruiting
- Azienda Ospedaliero Universitaria Di Bologna - Policlinico S. Orsola-Malpighi
Bologna, Italy
Completed - European Institute of Oncology (ieo), Irccs
Milan, Italy
Completed - European Institute of Oncology (ieo), Irccs ( Department of Urogenital and Head-and-Neck Medical Oncology)
Milan, Italy
Franco NoleRecruiting - Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Italy
Withdrawn - Humanitas San Pio X
Milan, Italy
Domenica LorussoRecruiting - National Cancer Institute, Irccs
Milan, Italy
Mara MantieroRecruiting - Irccs Policlinico Universitario Fondazione Agostino Gemelli
Roma, Italy
Vanda SalutariRecruiting - Irccs Istituto Clinico Humanitas - Research Hospital
Rozzano, Italy
Carmelo Carlo-StellaRecruiting
- Uniwersyteckie Centrum Kliniczne Gumed
Gdansk, Poland
Rafal DziadziuszkoRecruiting - Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
Gliwice, Poland
Completed - Pratia Mcm
Krakow, Poland
Withdrawn - Institute of Polish Mother Health Centre - Iczmp
Lodz, Poland
Withdrawn - Centrum Medyczne Pratia - Poznan
Poznan, Poland
Completed - University Teaching Hospital
Poznan, Poland
Radoslaw MadryRecruiting
- Novartis Investigative Site
Daegu, South Korea
Withdrawn - National Cancer Center
Goyang-si Gyeonggi-do, South Korea
Completed - Gachon University Gil Medical Center
Incheon, South Korea
Kwang-Beom LeeRecruiting - Asan Medical Center
Seoul, South Korea
Shinwha LeeRecruiting - Gangnam Severance Hospital
Seoul, South Korea
Jae-Hoon KimRecruiting - Seoul National University Hospital
Seoul, South Korea
Jae Weon KimRecruiting - the Catholic University of Korea, Yeouido St. Mary'S Hospital
Seoul, South Korea
Withdrawn - Yonsei Univ Health System Yucm
Seoul, South Korea
Jung-Yun LeeRecruiting
- Catalan Institute of Oncology
Barcelona, Spain
Withdrawn - Hospital Clinic of Barcelona
Barcelona, Spain
Begona Mellado GonzalezRecruiting - Hospital Vall D Hebron
Barcelona, Spain
Ana Oaknin BenzaquenRecruiting - Hospital Universitari de Girona Doctor Josep Trueta
Girona, Spain
Maria Pilar Barretina GinestaRecruiting - Hospital Universitario 12 de Octubre
Madrid, Spain
Completed - University Hospital Clinical San Carlos, Department of Medical Oncology
Madrid, Spain
Jorge Bartolome ArcillaRecruiting - University Hospital Foundation Jimenez Diaz
Madrid, Spain
Bernard Gaston Doger De Speville UribeRecruiting - University Hospital Ramon Y Cajal
Madrid, Spain
Teresa Alonso GordoaRecruiting - Puerta de Hierro Majadahonda University Hospital
Majadahonda, Spain
Aranzazu Gonzalez-Del-AlbaRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Sept 2019
- Primary completion
- 27 Feb 2030
- Completion
- 27 Feb 2030
- Last update posted
- 22 Jun 2026
- Registered enrollment
- 275
- Registry id
- NCT04104776
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.